For instance, TGFβ could be identified as a potent inhibitor of IL-6-mediated tumor-supportive effects [93], whereas Th9 cell-released IL-9 is apparently able to increase I-L6 and IL-9 production by intratumoral Th9 cells in an auto-amplifying loop [95]. The gene discussed is IL9; the disease is neoplasm.